Completion of the Placings

RNS Number : 9633Y

e-Therapeutics plc

01 March 2013

 

1 March 2013

e-Therapeutics plc ("e-Therapeutics" or the "Company")

Completion of the Placings

On 27 February 2013, e-Therapeutics plc (AIM: ETX) announced that it had gained shareholder approval to raise £40 million by issuing new equity through two share placings. On 28 February the First Placing of 4,750,000 ordinary shares was completed. Today, the Company announces that the Second Placing of 120,250,000 new ordinary shares has also been completed following the admission of these shares to trading on AIM.

Following completion of the Second Placing the Company has 263,222,468 ordinary shares in issue. The above figure may be used by shareholders as the denominator for the calculations by which they will determine whether they are required to notify their interest in, or a change to their interest in, e-Therapeutics plc under the Financial Services Authority's Disclosure and Transparency Rules.

-Ends-

For more information, please contact:

e-Therapeutics plc

Daniel Elger

Tel: [phone]

www.etherapeutics.co.uk 

Panmure Gordon (UK) Limited

Corporate Finance: Fred Walsh / Grishma Patel

Corporate Broking: Hannah Woodley

Tel: [phone]

www.panmure.com

 

END

 

 

IOELLFFTFIITFIV